Modalis Therapeutics Corporation

Corporate Details

ISIN(s):

N/A

LEI:

Country:

Japan

Address:

中央区日本橋本町三丁目１１番５号

Website:

https://modalistx.com/en/

Sector:

Manufacturing

Industry:

Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Modalis Therapeutics Corporation is a Japanese biotechnology company at the forefront of epigenome editing, dedicated to revolutionizing the treatment of genetic disorders. Utilizing its proprietary CRISPR-GNDM® technology, Modalis offers a novel approach to selectively target and regulate gene expression without altering the underlying DNA sequence. This advancement allows for precise modifications to the epigenome, restoring balance and addressing various diseases. With a robust pipeline that includes both in-house and collaborative development strategies, the company focuses on creating therapeutics for conditions such as muscular disorders, cardiomyopathy, and central nervous system (CNS) disorders. Committed to the belief that every life deserves attention, Modalis is poised to make significant contributions to the field of gene therapy.